Digitally created image of a double helix

Genetic Repositories Australia (GRA)

FACILITY INFORMATION

In accordance with NHMRC Enabling Grant requirements GRA has established 3 committees:

  • Management Committee
  • Scientific Advisory Committee
  • Independent Appeals Committee

The Management Committee (MC) operates under defined terms of reference and provides management and oversight of the day-to-day management of the GRA facility. The MC role is to ensure that appropriate ethical standards are met, ensuring open access to all researchers, and overseeing the resolution of any disputes consistent with NHMRC Enabling Facility Access Policy.

  • The GRA MC comprises the four Chief Investigators and the Facility Manager.
  • Professor Peter Schofield BScAgr, PhD, DSc
  • Executive Director & CEO, Neuroscience Research Australia
  • Assoc Prof Juleen Cavanaugh BSc, MS, PhD
  • Senior Lecturer, Australian National University
  • Dr Susan Forrest BSc (Hons), D Phil, BA Business
  • Director, Australian Genome Research Facility Ltd
  • Professor John Hopper BA, MSc, PhD
  • NHMRC Senior Principal Research Fellow, The University of Melbourne
  • Steve Turner BAppSc, BSc (Hons), MSc, Grad Cert Man
  • Facility Manager, Genetic Repositories Australia.

A Scientific Advisory Committee (SAC) which consists of nine members. The SAC membership reflects a skills-based committee, with an appropriate mix of expertise to allow the SAC to provide advice in all areas of operations of the GRA facility. GRA’s SAC provides strategic advice and reviews progress towards establishing and operating GRA as an NHMRC Enabling Facility, including advice on governance, management and operations. The SAC is comprised of a majority of external appointments & includes all members from the GRA MC and the Facility Manager (Ex Officio).

External SAC members are listed below:

  • Professor Graham MacDonald, Formerly External Licensing Coordinator, Merck Sharp & Dohme (Australia)
  • Professor Don Chalmers, Faculty of Law, University of Tasmania
  • Theo Magoulas, Assistant University Solicitor, University of Technology Legal Services
  • Professor Phil Mitchell, Head School of Psychiatry, University of NSW
  • Dr Bruce Ross, Health Solutions Executive, Health Solutions Group Microsoft Australia.

An Independent Appeals Committee (IAC) of ’eminent persons’ who are independent of GRA and represent a range of consumer, scientific and social scientific disciplines. The IAC has been established to resolve any dispute concerning access to or operations of the facility and comprises individuals outside both Management and the SAC. The IAC comprises the following members:

  • Professor Ron Trent, Professor of Medicine at University of Sydney and Royal Prince Alfred Hospital
  • Peter Kemp, Founder of Kemp Strang Lawyers
  • A Consumer or Community Representative, (Position currently vacant)
See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

During three decades on Australian television, two simple words brought us to attention.

‘Hello daaaahling’. Outrageous, flamboyant, iconic – Jeanne Little captivated Australians everywhere with her unique style, cockatoo shrill voice and fashion sense. "Mum wasn't just the life of the party, she was the party.” Katie Little, Jeanne’s daughter remembers. This icon of Australian television brought a smile into Australian homes. Tragically, today Jeanne can't walk, talk or feed herself. She doesn't recognise anyone, with a random sound or laugh the only glimpse of who she truly is. Jeanne Little has Alzheimer's disease. The 1,000 Brains Study NeuRA is very excited to announce the 1,000 Brains Study, a ground-breaking research project to identify the elements in our brains that cause life-changing neurodegenerative diseases like Alzheimer’s, Parkinson’s and other dementias. This study will focus on the key unresolved question: why do some of us develop devastating neurodegenerative diseases, while others retain good brain health? The study will compare the genomes of people who have reached old age with healthy brains against the genomes of those who have died from neurodegenerative diseases, with post mortem examination of brain tissue taking place at NeuRA’s Sydney Brain Bank. More information on the study can be found here. Will you please support dementia research and the 1,000 Brains Study and help drive the future of genetics research in Australia? https://youtu.be/q7fTZIisgAY
APPEAL